Therapeutic Advances in the Treatment of Polycystic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|128|3-4|297-302

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.128, Iss.3-4, 2015-0, pp. : 297-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic advances in the treatment of Peyronie's disease

By  

ANDROLOGY, Vol. 3, Iss. 4, 2015-07 ,pp. : 650-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Renal Cell Carcinoma in Cases of Adult Polycystic Kidney Disease: Changing Diagnostic and Therapeutic Implications

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 9-12

Karger

Access to resources Recommend Favorite

Practical Genetics for Autosomal Dominant Polycystic Kidney Disease

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2010-11 ,pp. : c19-c30

Karger

Access to resources Recommend Favorite

Systems biology of polycystic kidney disease: a critical review

By  

WILEY INTERDISCIPLINARY REVIEWS: SYSTEMS BIOLOGY AND MEDICINE (ELECTRONIC), Vol. 7, Iss. 1, 2015-01 ,pp. : 39-52

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Treatment with Mammalian Target of Rapamycin Inhibitor Does Not Benefit Patients with Autosomal Dominant Polycystic Kidney Disease: A Meta-Analysis

By  

Nephron Clin Pract, Vol. 124, Iss. 1-2, 2013-09 ,pp. : 10-16

Karger

Access to resources Recommend Favorite